Last reviewed · How we verify
NCT06194084: DURIOME
Impacts of Durian Consumption on Human Microbiome and Metabolome in Healthy Staff Volunteers
NA trial testing Two-sequence of durian pulp doses (100 g and 200 g) in Diet, Food and Nutrition in 45 participants. Completed in 29 August 2025.
29 August 2025
Quick facts
| Lead sponsor | National Cancer Centre, Singapore |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 45 |
| Start date | 1 February 2023 |
| Primary completion | 29 August 2025 |
| Estimated completion | 29 August 2025 |
| Sites | 1 location across Singapore |
Drugs / interventions tested
- Two-sequence of durian pulp doses (100 g and 200 g)
Conditions studied
- Diet, Food and Nutrition — all drugs for Diet, Food and Nutrition →
Sponsor
National Cancer Centre, Singapore
Who can join
Adults 21 to 60, any sex, with Diet, Food and Nutrition. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical study investigates the impacts of daily durian consumption on gut microbiota, gut microbial metabolites, and host metabolome in healthy individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06194084
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diet, Food and Nutrition
Currently open trials in the same condition.
- NCT06586970 — Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients · NA · recruiting
Other National Cancer Centre, Singapore trials
Trials by the same sponsor.
- NCT07428356 — Histotripsy for Ablation of Liver Tumours in Asia · NA · recruiting
- NCT07428655 — Acceptability and Feasibility of PSC Model of Serious Illness Communication · NA · active not recruiting
- NCT07116161 — Exercise Therapy and Cognitive Behavioural Therapy for Fatigue in Female Cancer Patients in Singapore · NA · recruiting
- NCT06977360 — Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solutio · NA · recruiting
- NCT06766058 — Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06194084 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Cancer Centre, Singapore
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06194084.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing